標(biāo)題：Research Grade Solitomab 索利托單抗,AntibodySystem Laboratories

鏈接：https://www.antibodysystem.com/product/370.html

名稱：Research Grade Solitomab索利托單抗

別名：Solitomab索利托單抗，Bispecific, MT110, AMG110, AMG-110, AMG110,

CAS: 1005198-65-1

貨號(hào)：DHD17407

適用物種：Human

寄主物種：Mus musculus

形式：Liquid

純度：>95%

克隆性：Monoclonal

同種型：(scFv-kappa-heavy)-(scFv-heavy-kappa)

應(yīng)用：Research Grade Biosimilar

UniProt：P16422 & P07766

靶點(diǎn)：Epithelial glycoprotein 314, hEGP314, Major gastrointestinal tumor-associated protein GA733-2, EGP314, TACSTD1, Adenocarcinoma-associated antigen, TROP1, EPCAM, Epithelial glycoprotein, KS 1/4 antigen, Tumor-associated calcium signal transducer 1, M4S1, CD326, Ep-CAM, EGP, Epithelial cell adhesion molecule, M1S2, KSA, Cell surface glycoprotein Trop-1, GA733-2, Epithelial cell surface antigen, MIC18, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain

用途范圍：僅用于科研

儲(chǔ)存：Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

產(chǎn)品購(gòu)買聯(lián)系方式：027-65279366 /18162686757

郵箱：biolab-reagents@atagenix.com

QQ：2663991332

參考文獻(xiàn)：

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro. PMID: 26272866

Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro. PMID: 26474755

Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo. PMID: 25251053

EpCAM expression in esophageal cancer and its correlation with immunotherapy of solitomab. PMID: 34012588

A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE) antibody construct, in patients with refractory solid tumors. PMID: 30221040

A Novel Hydrogel-Based 3D In Vitro Tumor Panel of 30 PDX Models Incorporates Tumor, Stromal and Immune Cell Compartments of the TME for the Screening of Oncology and Immuno-Therapies. PMID: 37190054

Novel Fab-peptide-HLA-I fusion proteins for redirecting pre-existing anti-CMV T cell immunity to selective eliminate carcinoma cells. PMID: 37180637